HOME >> BIOLOGY >> NEWS
Epilepsy drug poses high risk for fetal death and birth defects

St. Paul, Minn. -- The epilepsy drug valproate poses a higher risk for fetal death and birth defects than other commonly used epilepsy drugs, according to a study published in the August 8, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

Of the four epilepsy drugs tested in the study, valproate posed the highest risk to the fetus with over 20 percent of the pregnancies exposed to valproate resulting in death or birth defects such as skull and limb deformities and brain, heart and lung problems.

The rate was lower for the drugs phenytoin, carbamazepine and lamotrigine. The study's findings are consistent with several other recent studies.

"The evidence is compelling that valproate poses a higher risk of birth defects than other commonly used epilepsy drugs," said study author Kimford Meador, MD, of the University of Florida in Gainesville, Florida and a fellow at the American Academy of Neurology. "Unfortunately, many doctors and pregnant women aren't aware of the risks."

The study examined 333 pairs of mother and child in the United States and the United Kingdom.

Meador is recommending doctors talk with their patients about the risks associated with valproate when choosing an epilepsy drug for women of child-bearing age. Patients already taking valproate should also be advised of the risk.

"Although valproate will continue to be an important treatment option in women who aren't able to use other epilepsy drugs, we're advising valproate not be used as the drug of first choice for women of child bearing potential, and when used, its dosage should be limited if possible," said Meador.


'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
7-Aug-2006


Page: 1

Related biology news :

1. Epilepsy drug eases symptoms of inherited disorder that weakens muscles
2. Epilepsy by the numbers
3. Epilepsy Foundation announces free forum
4. Epilepsy and depression - A two-way street?
5. Cat hair at home poses an allergy risk, particularly for young children
6. Replacement warhead program poses challenges for weapons complex
7. Carnegie Mellon researcher proposes development of artificial cells to fight disease
8. Malaria poses additional risks for first-time mothers
9. One-two particle punch poses greater risk for astronauts
10. Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
11. SNM opposes new payment caps on imaging services detailed in Federal Deficit Reduction Act

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2019)... SCARBOROUGH, Maine (PRWEB) , ... ... ... instrumentation manufacturer Fluid Imaging Technologies ( http://www.fluidimaging.com ) announced today the release ... the FlowCam automated particle imaging and characterization platform will provide a significant ...
(Date:7/17/2019)... ... July 18, 2019 , ... ... Meredith James, HT, PMP, to its executive team as Vice President of Operations. ... drug development. In her new role, Ms. James is responsible for ensuring on-time ...
(Date:7/17/2019)... ... July 16, 2019 , ... At nearly eleven years ... legs. According to his owner, in the last year or so, he was ... His veterinarian, Dr. Cindy Echevarria of VCA University Animal Hospital in ...
Breaking Biology News(10 mins):
(Date:7/2/2019)... POWAY, Calif. (PRWEB) , ... July 02, 2019 , ... ... new documentary entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on ... and wild animals. Animal Pharm was recently included in the Brentwood ...
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
(Date:6/11/2019)... ... 2019 , ... Advancements with Ted Danson will focus on ... 4Q/2019. Check your local listings for more information. , Advancements will explore Bio-ITech ... facilitates laboratories to improve efficiency and quality of research by providing comprehensive and ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility for ... and Drug Branch for manufacturing. This is an important milestone for VetStem ...
Breaking Biology Technology:
Cached News: